RESUMO
@# The “eighteen antagonisms” of Chinese medicinals have been regarded as taboos in the field of traditional Chinese medicine （TCM）， and the connotations have gradually been narrowed down in the development of TCM. From the historical perspective， “eighteen antagonisms” are not an absolute taboo in terms of the combination of medicinals， and the existing types of antagonism medicinals are also worth further discussion. From the perspective of toxicological effects， the toxicology of the “eighteen antagonisms” mainly comes from the enhancement of the toxic and side effects of a certain herb， rather than the combination of two herbs. From the perspective of pharmacodynamic actions， the combination of some antagonism medicinals can achieve therapeutic effects that cannot obtained by conventional medicinals， which is feasible and reasonable in clinical practice. Therefore， it is believed that the application of combining some antagonism medicinals based on “eighteen antagonisms” is of positive significance. Moreover， strict combination， processing and decoction methods should be noted in the use of antagonism medicinals. All mentioned above will provide reference for the correct recognition and use of the combination of “eighteen antagonisms”， and broaden the combination thinking for the treatment of clinical diseases with TCM.
RESUMO
The “eighteen antagonisms” of Chinese medicinals have been regarded as taboos in the field of traditional Chinese medicine （TCM）， and the connotations have gradually been narrowed down in the development of TCM. From the historical perspective， “eighteen antagonisms” are not an absolute taboo in terms of the combination of medicinals， and the existing types of antagonism medicinals are also worth further discussion. From the perspective of toxicological effects， the toxicology of the “eighteen antagonisms” mainly comes from the enhancement of the toxic and side effects of a certain herb， rather than the combination of two herbs. From the perspective of pharmacodynamic actions， the combination of some antagonism medicinals can achieve therapeutic effects that cannot obtained by conventional medicinals， which is feasible and reasonable in clinical practice. Therefore， it is believed that the application of combining some antagonism medicinals based on “eighteen antagonisms” is of positive significance. Moreover， strict combination， processing and decoction methods should be noted in the use of antagonism medicinals. All mentioned above will provide reference for the correct recognition and use of the combination of “eighteen antagonisms”， and broaden the combination thinking for the treatment of clinical diseases with TCM.
RESUMO
The incompatibility of Chinese materia medica (CMM) has always been one of the important scientific issues of CMM safety research. Extensive researches about CMM incompatibility have been carried out represented by "eighteen-antagonisms", mainly focused on the safety evaluation, toxic effects of substances, toxicology, toxicokinetics, drug interactions, toxicity mechanisms, etc. However, due to lack of system design on research ideas, model and methods, many key issues still lacked reliable conclusions, and did not reach a consensus within the industry. We completed the toxicity-effect characterization of the anti-drugs about "Pinelliae Rhizoma, Trichosanthis Fructus, Fritillariae Cirrhosae Bulbus, Ampelopsis Radix, and Bletillae Rhizoma attack Aconiti Radix" and proposed that the serious adverse reactions caused by related anti-drug combination therapy were because of the "toxicity" of CMM incompatibility. The formation of CMM incompatibility was closely related to its composition, dose, compatibility environment, etc, wherein the disease and symptom are the key factors of incompatibility. Eventually, the research model of toxicity-effect characterization of CMM incompatibility based on the desease and symptom was formed, it was viable to provide new strategies and methods for the clinical drug safety of CMM compatibility.
RESUMO
Objective: Under the guidance of eighteen antagonisms of Chinese materia medica, to analyze the effect of Aconiti Radix Cocta combined with Ampelopsis Radix in different ratios on the characteristic constituents and to explore the in vitro compatibility mechanism of Aconiti Radix Cocta and Ampelopsis Radix. Methods: A certain weight of Aconiti Radix Cocta was combined with various amounts of Ampelopsis Radix, and a rapid resolution liquid chromatography coupled with quadruple-time-of-flight mass spectrometry (RRLC-Q-TOF-MS) method based on chemical profiling approach was used to determine the content of alkaloids in decoctions and sediments. The aconitine alkaloids were established and were subjected to PLS-DA and ANOVA to provide intergroup difference and distribution characteristics. In addition, the method of UV spectrophotometer was adopted to determine the content of starch and tannins in Ampelopsis Radix. Results: There were certain differences among each group, especially between the single Aconiti Radix Cocta and Aconiti Radix Cocta combined with Ampelopsis Radix at the ratio of 1:3. With the increasing of the ratio of Ampelopsis Radix in the combination, the content of alkaloids appeared to increase in the decoction while decrease in the sediment. After determination, the mass fractions of starch and tannic acid in Ampelopsis Radix were 25.44% and 0.31%, respectively. Conclusion: The aconitine alkaloids could be deposited with the starch in Ampelopsis Radix, meanwhile decreased in the decoction, which establishes the foundation for the further research on the chemical mechanism of Aconiti Radix Cocta combined with Ampelopsis Radix.